Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders

Pär I Johansson, Sisse R OstrowskiCapital Region Blood Bank, Section for Transfusion Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, DenmarkBackground: Recombinant activated factor VII (rFVIIa, NovoSeven®) was introduced in 1996 for the treatment of hemophilic patien...

全面介绍

Saved in:
书目详细资料
Main Authors: Pär I Johansson (Author), Sisse R Ostrowski (Author)
格式: 图书
出版: Dove Medical Press, 2010-06-01T00:00:00Z.
主题:
在线阅读:Connect to this object online.
标签: 添加标签
没有标签, 成为第一个标记此记录!

因特网

Connect to this object online.

3rd Floor Main Library

持有资料详情 3rd Floor Main Library
索引号: A1234.567
复印件 1 可用